Systematic literature review and network meta-analysis of treatment outcomes in relapsed and/or refractory multiple myeloma

…, HM Blommestein, CA Uyl-de Groot… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Since 2000, many new treatment options have become available for relapsed and/or
refractory multiple myeloma (R/R MM) after a long period in which dexamethasone and …

Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia

MT Groot, R Baltussen, CA Uylde Groot… - The breast …, 2006 - Wiley Online Library
We estimated the costs and health effects of treating stage I, II, III, and IV breast cancer
individually, of treating all stages, and of introducing an extensive cancer control program (…

[PDF][PDF] Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized …

…, EF Comans, P Verboom, CA Uyl-de Groot… - J Clin Oncol, 2006 - academia.edu
Uyl-de Groot, Alle Welling, Marinus A. Paul, Maarten Boers, Pieter E. Postmus, Gerrit J. …
Smit, Harm van Tinteren, Carin A. Uyl-de Groot, Maarten Boers, Pieter E. Postmus, Gerrit J …

[HTML][HTML] Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets …

T Gronde, CA Uyl-de Groot, T Pieters - PloS one, 2017 - journals.plos.org
Context Recent public outcry has highlighted the rising cost of prescription drugs worldwide,
which in several disease areas outpaces other health care expenditures and results in a …

Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study

…, EWM Grijseels, GJJ Teule, CA Uyl-de Groot… - European journal of …, 2003 - Springer
Currently, up to 50% of the operations in early-stage non-small cell lung cancer (NSCLC)
are futile owing to the presence of locally advanced tumour or distant metastases. More …

[HTML][HTML] An artificial intelligence based app for skin cancer detection evaluated in a population based setting

…, LJ Bakker, L Hollestein, CA Uylde Groot… - NPJ digital …, 2023 - nature.com
Artificial intelligence (AI) based algorithms for classification of suspicious skin lesions have
been implemented in mobile phone apps (mHealth), but their effect on healthcare systems is …

[HTML][HTML] Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands

…, JBAG Haanen, H Gelderblom, CA Uyl-de Groot… - European Journal of …, 2017 - Elsevier
Background In recent years, the treatment of metastatic melanoma has changed dramatically
due to the development of immune checkpoint and mitogen-activated protein (MAP) kinase …

[HTML][HTML] Condition-specific preference-based measures: benefit or burden?

MM Versteegh, A Leunis, CA Uyl-de Groot, EA Stolk - Value in Health, 2012 - Elsevier
Objectives Some argue that generic preference-based measures (PBMs) are not sensitive
to certain disease-specific improvements. To overcome this problem, new condition-specific …

[HTML][HTML] Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective

I Houda, C Dickhoff, CA Uyl-de Groot… - The Lancet Regional …, 2024 - thelancet.com
The treatment landscape of resectable early-stage non-small cell lung cancer (NSCLC) is
transforming due to the approval of novel adjuvant and neoadjuvant systemic treatments. The …

Two decades of targeted therapies in acute myeloid leukemia

…, TB Polak, GJ Ossenkoppele, CA UylDe Groot… - Leukemia, 2021 - nature.com
Precision medicine is gaining importance in the treatment of acute myeloid leukemia (AML).
Objectively reviewing past and current knowledge aids guiding future research. Therefore, …